Back to results
Bibliographic record · Consultation and access
Artículo

18F-FDG PET/MR reveals specific brain metabolic features in Parkinson’s disease with frailty

Guoyang Li et al · Frontiers Media S.A · 2026

Open access available
Quick overview. Review the resource’s basic details, then access the content using the main button. This page shows only the information needed to identify, cite, and open the work.

Resource access

Open the content from the main option or choose another available source.

DOAJ DOAJ Articles
Entrar por DOAJ
Main access

Open access available

Recurso identificado como acceso abierto, sin confirmar automáticamente si es texto completo directo.
Open resource

Summary

Descripción general del contenido del recurso.

BackgroundFrailty is significantly more prevalent in individuals with Parkinson’s disease (PD) than in general population, yet the underlying neuropathophysiological mechanisms remain poorly understood. This study aimed to characterize the clinical features and cerebral metabolic patterns of frail PD patients using [18F]-fluorodeoxyglucose positron emission tomography (18F-FDG PET), and to explore the potential pathophysiological mechanisms.MethodsA total of 64 PD patients treated at Shenzhen People’s Hospital underwent 18F-FDG PET/MR imaging during June-December 2024. Age- and sex-matched healthy controls were also recruited (n = 17). For PD patients, frailty was assessed using the Fried criteria. Patient demography, cognitive performance, and clinical variables—including UPDRS-III scores—were compared between frail and non-frail PD patients. Regional brain metabolism, measured as 18F-FDG SUVr, was analyzed in brain regions defined by the Automated Anatomical Labeling (AAL) atlas.ResultsAmong the PD cohort (mean age: 66.86 ± 6.97 years; 30 female), 34 were classified as non-frail (mean age: 64.29 ± 6.61 years; 16 female) and 30 as frail (mean age: 69.77 ± 6.17 years; 14 female). Compared to the non-frail group, frail PD patients were significantly older (P = 0.001) and exhibited more severe motor symptoms (UPDRS-III, P < 0.001; modified Hoehn & Yahr (Modified H&Y) stage, P = 0.028), along with greater cognitive impairment (P < 0.001). Although the daily levodopa equivalent dose did not differ significantly between groups (P = 0.076), a trend toward higher dosage was observed in the frail group. 18F-FDG PET/MR analysis revealed significantly reduced glucose metabolism in 13 brain regions in frail PD patients compared to non-frail patients: Frontal_Mid_L (P = 0.0056), Frontal_Mid_Orb_L (P = 0.0045), Frontal_Inf_Tri_R (P = 0.0053), Occipital_Mid_L (P = 0.0035), Occipital_Inf_L (P = 0.0053), Parietal_Inf_R (P = 0.0003), Angular_L (P = 0.0015), Angular_R (P = 0.0003), Caudate_L (P = 0.0052), Caudate_R (P = 0.0019), Temporal_Mid_R (P = 0.0040), Temporal_Inf_L (P = 0.0048), and Temporal_Inf_R (P = 0.0046). Correlation analyses revealed distinct region-function associations in the cognitive domains of frail PD patients. Regression analysis indicated that hypometabolism in the Temporal_Inf_R was significantly associated with UPDRS-III scores in the frail group.ConclusionFrailty in PD is associated with advanced age, greater motor severity, and possibly increased medication needs. Frail PD patients exhibit specific patterns of cerebral hypometabolism and more severe cognitive deficits. Distinct brain regions are differentially associated with specific cognitive domains. Notably, reduced metabolism in the Temporal_Inf_R is significantly related to motor symptom severity in frail PD, suggesting a key region in the pathophysiology of frailty in PD.

How to cite

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

al, G. L. E. (2026). 18F-FDG PET/MR reveals specific brain metabolic features in Parkinson’s disease with frailty. https://doi.org/10.3389/fnagi.2025.1624203

MLA

al, Guoyang Li et. "18F-FDG PET/MR reveals specific brain metabolic features in Parkinson’s disease with frailty." 2026. https://doi.org/10.3389/fnagi.2025.1624203.

Chicago

al, Guoyang Li et. 2026. "18F-FDG PET/MR reveals specific brain metabolic features in Parkinson’s disease with frailty.". https://doi.org/10.3389/fnagi.2025.1624203.

Harvard

al, G. L. E. 2026, 18F-FDG PET/MR reveals specific brain metabolic features in Parkinson’s disease with frailty, Frontiers Media S.A, available at: https://doi.org/10.3389/fnagi.2025.1624203 [Accessed 9 Aug. 2026].

Share and print

Save the record, copy its permanent link, or print it as a PDF.

Export reference

You can export the record in common formats for use in a reference manager.

Resource details

Bibliographic information to help confirm that this is the correct material.

Title
18F-FDG PET/MR reveals specific brain metabolic features in Parkinson’s disease with frailty
Author / contributors
Guoyang Li et al
Publisher
Frontiers Media S.A
Publication year
2026
ISSN
1663-4365
ISSN
1663-4365
Language
English

Subjects

Explore related resources through these subjects.

Copied